Inno Vita Hysta-Min Review

Inno Vita Hysta-Min is a dietary supplement formulated by Inno-Vita, designed to support the body's natural response to environmental allergens and help mitigate negative inflammatory responses. Available in both 60-count capsules and a 1 oz. liquid extract, Hysta-Min is intended for use under the guidance of a licensed health practitioner, reflecting Inno-Vita's professional distribution model. The product's stated purpose is to "Neutralize / Regulate" and offer "Inflammation Support," suggesting a role in modulating the body's immune and inflammatory pathways when exposed to environmental triggers. While the precise, detailed mechanisms of action are not extensively disclosed in publicly available information, the general intent is to bolster the body's intrinsic ability to manage allergic reactions and reduce associated inflammation. Users are typically directed to take one or two capsules up to twice daily, or 5-6 drops of the liquid extract orally three to four times daily, with an emphasis on increasing liquid intake during supplementation. However, a comprehensive understanding of Hysta-Min's native mechanisms is limited by the lack of a publicly accessible, detailed "Supplement Facts" panel. A 2017 FDA warning letter to Inno-Vita highlighted concerns regarding ingredient labeling for several products, including Hysta-Min. The FDA noted that "Rice Flower" was listed as an ingredient, suggesting it might be a misspelling of "rice flour." Furthermore, the letter indicated that "Thymus FormCode" and "Polysaccharide" were declared as dietary ingredients without providing their common or usual names or specifying the individual polysaccharide, which the FDA deemed non-compliant with labeling regulations. These labeling issues prevent a thorough analysis of the specific active compounds and their physiological roles in supporting allergen response and reducing inflammation. Without a clear list of active ingredients and their standardized names, a detailed explanation of how each component contributes to the product's purported benefits cannot be provided.